Interferon production by cultured peripheral leucocytes of MS patients
- PMID: 6206970
- PMCID: PMC1576981
Interferon production by cultured peripheral leucocytes of MS patients
Abstract
Peripheral blood leucocytes from multiple sclerosis (MS) patients and from normal individuals were tested for their interferon (IFN) producing capacity after stimulation in vitro with various lectins and viruses. The lectins, Con A, PHA and PWM, induced IFN-gamma. In a kinetic study, the response to Con A revealed itself as an all or none event: the number of responding cultures increased with increasing mitogen dose, but the IFN yield in responding cultures did not differ significantly between dose levels. Thus, any patient or donor could easily be rated as a responder or non-responder. About 1/2 of the MS patients were found to be non-responders if Con A or PHA were used as stimuli. Ninety per cent of the normal donors on the other hand were responders. With PWM as a stimulus 100% of both the MS patients and normal donor groups were found to be responders. Also, with PWM very small doses were sufficient to obtain a 100% response rate among tested cultures, and IFN production persisted for 5 days, while with Con A or PHA it was arrested after 2-3 days. The results indicate that the MS associated lesion is not the absence of functional impairment of all IFN-gamma producing cells, but in only a fraction of them or in an accessory cell population required for the response to Con A and PHA but not to PWM. Newcastle disease virus (NDV) and vesicular stomatitis virus (VSV) both induced IFN-alpha. With NDV as the inducer response rates were 100% and yields were high irrespective of whether the cells were derived from patients or control donors. In contrast, with VSV as the inducer lower response rates were found in cultures from MS patients than in those from controls.
Similar articles
-
Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases.Clin Exp Immunol. 1985 Feb;59(2):391-7. Clin Exp Immunol. 1985. PMID: 3919978 Free PMC article.
-
Influence of acute and chronic ethanol treatment on interferon production in mice.Arch Immunol Ther Exp (Warsz). 1994;42(3):239-46. Arch Immunol Ther Exp (Warsz). 1994. PMID: 7487360
-
In vitro and in vivo interferon production in NOD mice.Lab Anim Sci. 1989 Nov;39(6):575-8. Lab Anim Sci. 1989. PMID: 2512417
-
PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables.Ann Neurol. 1982 Mar;11(3):279-84. doi: 10.1002/ana.410110308. Ann Neurol. 1982. PMID: 6178361
-
Interferon production by peripheral blood cells of patients with alcoholic liver disease (ALD).Arch Immunol Ther Exp (Warsz). 1994;42(3):231-8. Arch Immunol Ther Exp (Warsz). 1994. PMID: 7487359
Cited by
-
Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases.Clin Exp Immunol. 1985 Feb;59(2):391-7. Clin Exp Immunol. 1985. PMID: 3919978 Free PMC article.
-
Interferons in multiple sclerosis. A review of the evidence.Drugs. 1992 Dec;44(6):946-62. doi: 10.2165/00003495-199244060-00004. Drugs. 1992. PMID: 1282865 Review.
-
In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosis.Clin Exp Immunol. 1985 Sep;61(3):556-61. Clin Exp Immunol. 1985. PMID: 3935348 Free PMC article.
-
Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.Clin Exp Immunol. 1986 Nov;66(2):285-94. Clin Exp Immunol. 1986. PMID: 2949897 Free PMC article.
-
Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.Clin Exp Immunol. 1999 Mar;115(3):521-5. doi: 10.1046/j.1365-2249.1999.00816.x. Clin Exp Immunol. 1999. PMID: 10193428 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical